Tolterodine tartrate - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for tolterodine tartrate and what is the scope of freedom to operate?
Tolterodine tartrate
is the generic ingredient in three branded drugs marketed by Upjohn, Ajanta Pharma Ltd, Aurobindo Pharma Usa, Hetero Labs Ltd Iii, Inventia Hlthcare, Teva Pharms Usa, Torrent, Unichem, Utopic Pharms, Apotex Corp, Elysium, Hetero Labs Ltd V, Ivax Sub Teva Pharms, Macleods Pharms Ltd, Norvium Bioscience, and Unique, and is included in eighteen NDAs. Additional information is available in the individual branded drug profile pages.There are twenty-two drug master file entries for tolterodine tartrate. Twenty suppliers are listed for this compound. There are two tentative approvals for this compound.
Summary for tolterodine tartrate
US Patents: | 0 |
Tradenames: | 3 |
Applicants: | 16 |
NDAs: | 18 |
Drug Master File Entries: | 22 |
Finished Product Suppliers / Packagers: | 20 |
Raw Ingredient (Bulk) Api Vendors: | 184 |
Clinical Trials: | 16 |
Patent Applications: | 5,872 |
Drug Prices: | Drug price trends for tolterodine tartrate |
Drug Sales Revenues: | Drug sales revenues for tolterodine tartrate |
What excipients (inactive ingredients) are in tolterodine tartrate? | tolterodine tartrate excipients list |
DailyMed Link: | tolterodine tartrate at DailyMed |
Recent Clinical Trials for tolterodine tartrate
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Shanghai Institute of Acupuncture, Moxibustion and Meridian | N/A |
RenJi Hospital | N/A |
University of California, San Francisco | Phase 4 |
Generic filers with tentative approvals for TOLTERODINE TARTRATE
Applicant | Application No. | Strength | Dosage Form |
⤷ Sign Up | ⤷ Sign Up | 1MG | TABLET; ORAL |
⤷ Sign Up | ⤷ Sign Up | 2MG | TABLET; ORAL |
⤷ Sign Up | ⤷ Sign Up | 2MG | TABLET; ORAL |
The 'tentative' approval signifies that the product meets all FDA standards for marketing, and, but for the patents / regulatory protections, it would approved.
Pharmacology for tolterodine tartrate
Drug Class | Cholinergic Muscarinic Antagonist |
Mechanism of Action | Cholinergic Muscarinic Antagonists |
Medical Subject Heading (MeSH) Categories for tolterodine tartrate
Anatomical Therapeutic Chemical (ATC) Classes for tolterodine tartrate
Paragraph IV (Patent) Challenges for TOLTERODINE TARTRATE
Tradename | Dosage | Ingredient | Strength | NDA | ANDAs Submitted | Submissiondate |
---|---|---|---|---|---|---|
DETROL LA | Extended-release Capsules | tolterodine tartrate | 2 mg and 4 mg | 021228 | 1 | 2007-07-30 |
US Patents and Regulatory Information for tolterodine tartrate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Unichem | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 205399-001 | Aug 5, 2020 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Torrent | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 203016-001 | Aug 11, 2015 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Elysium | TOLTERODINE TARTRATE | tolterodine tartrate | TABLET;ORAL | 210775-001 | Dec 30, 2019 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Teva Pharms Usa | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 079141-002 | Nov 22, 2016 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Unichem | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 216917-001 | Aug 27, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
Unichem | TOLTERODINE TARTRATE | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 216917-002 | Aug 27, 2024 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for tolterodine tartrate
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-002 | Mar 25, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL | tolterodine tartrate | TABLET;ORAL | 020771-001 | Mar 25, 1998 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-001 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
Upjohn | DETROL LA | tolterodine tartrate | CAPSULE, EXTENDED RELEASE;ORAL | 021228-002 | Dec 22, 2000 | ⤷ Sign Up | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.